Previous 10 | Next 10 |
home / stock / vktx / vktx articles
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter...
Tuesday, Viking Therapeutics Inc (NASDAQ:VKTX) released results from the company’s Phase 1 multiple ascending dose (MAD) trial of a...
Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading lower by 10.9% to $63.95 Monday afternoon, despite a lack of company-specific news for the...
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-q...
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 46.96% on an annualized basis producing an average annual re...
The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the 2021 highs. David Prince, pr...
Viking Therapeutics Inc (NASDAQ:VKTX) recently released top-line results from a successful Phase 2 weight loss trial. Patients receiving VK2735 d...
During Tuesday’s CNBC Investing Club Morning Meeting, U.S. stocks exhibited mixed performance, prompting a closer look at prevailing market t...
On Tuesday, the U.S. indices exhibited a varied performance, as the S&P 500 rose by nearly 0.2% to reach 5,078.18, while the Dow Jones Industri...
News, Short Squeeze, Breakout and More Instantly...
Viking Therapeutics Inc. Company Name:
VKTX Stock Symbol:
NASDAQ Market:
Viking Therapeutics Inc. Website:
2024-07-01 08:15:00 ET Few biotech companies have made more noise than Viking Therapeutics (NASDAQ: VKTX) this year, and that's saying something. The drugmaker had been a relatively small and unknown player in the industry. However, Viking's prominence and stock price soared thanks ...
2024-06-30 06:53:00 ET Altimmune (NASDAQ: ALT) and Viking Therapeutics (NASDAQ: VKTX) have a lot of features in common, but, at least for the moment, the performance of their stocks is not one of them. Whereas Viking's shares are up by 610% over the last three years, Altimmu...